TCT 2024 Late-Breaking Science Collection

  • Published:  17 October 2024
  • Likes: 

    Heart Icon

    1

Up Next

TCT 2024 Late-Breaking Science Collection

  • Published:  17 October 2024
  • Likes: 

    Heart Icon

    1

Average (ratings)
No ratings
Your rating
About the episode

TCT 2024 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference.

Dive into this practical and engaging discussion and learn more about the latest data for practice and for research.

Trials covered in detail include:

ECLIPSE (00:49 - 05:55)
FAVOR III (05:55 - 10:30)
FLASH (10:30 - 12:54)
DCB BIFURCATION (12:54 - 15:17)
EARLY TAVR (15:17 - 21:14)
EVOLVED (21:14 - 24:07)
TAVR-UNLOAD (24:07 - 28:57)
PEERLESS (28:57 - 31:14)
CLEAR IE (31:14 - 33:29)
TRISCEND II (33:29 - 36:36)
ACCESS TAVI (36:36 - 40:05)
ALIGN AR (40:05 - 41:49)
COSTAR RCT (41:49 - 43:36)
ACURATE IDE (43:36 - 46:42)
CLEAR SYNERGY(46:42 - 48:41)

Support: This is an independent interview produced by Radcliffe Cardiology. 

Overview

Keep informed with our video collection unveiling data from the Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage.

  • For practice-focused reviews of the most anticipated trials, watch our recurring View From the Thoraxcenter series, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
  • Our short Expert Interviews with select faculty offer focused data analysis and take-home messages for practice.
  • To delve deeper into insights on the most pertinent trials, catch our Highlights.

Dive into the latest cardiology research with our upcoming TCT Conference coverage.

More from this programme

Faculty Biographies

Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile
Nicolas M Van Mieghem

Nicolas M Van Mieghem

Full Professor of Interventional Cardiology

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

 

Academic History

Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.